X-119085501-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001394962.1(KIAA1210):āc.4202T>Cā(p.Val1401Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,097,392 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001394962.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIAA1210 | NM_001394962.1 | c.4202T>C | p.Val1401Ala | missense_variant | 10/12 | ENST00000691062.1 | NP_001381891.1 | |
KIAA1210 | NM_020721.1 | c.4730T>C | p.Val1577Ala | missense_variant | 12/14 | NP_065772.1 | ||
KIAA1210 | XM_017029688.3 | c.4247T>C | p.Val1416Ala | missense_variant | 10/12 | XP_016885177.1 | ||
KIAA1210 | XM_017029689.3 | c.4049T>C | p.Val1350Ala | missense_variant | 9/11 | XP_016885178.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIAA1210 | ENST00000691062.1 | c.4202T>C | p.Val1401Ala | missense_variant | 10/12 | NM_001394962.1 | ENSP00000510348.1 | |||
KIAA1210 | ENST00000402510.2 | c.4730T>C | p.Val1577Ala | missense_variant | 12/14 | 5 | ENSP00000384670.2 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097392Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 362840
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.